A carregar...
Comparability of PD‐L1 immunohistochemistry assays for non‐small‐cell lung cancer: a systematic review
Programmed cell death ligand 1 (PD‐L1) immunohistochemistry is used to determine which patients with advanced non‐small‐cell lung cancer (NSCLC) respond best to treatment with PD‐L1 inhibitors. For each inhibitor, a unique immunohistochemical assay was developed. This systematic review gives an up‐t...
Na minha lista:
| Publicado no: | Histopathology |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7318295/ https://ncbi.nlm.nih.gov/pubmed/31793055 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/his.14040 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|